Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i

K. Kobayashi; H. Yokoh; Y. Sato; M. Takemoto; D. Uchida; A. Kanatsuka; N. Kuribayashi; T. Terano; N. Hashimoto; K. Sakurai; H. Hanaoka; K. Ishikawa; S. Onishi; K. Yokote;

doi:10.1111/dom.12264

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i

Diabetes Obesity and Metabolism ◽

10.1111/dom.12264 ◽

2014 ◽

Vol 16 (8) ◽

pp. 761-765 ◽

Cited By ~ 12

Author(s):

K. Kobayashi ◽

H. Yokoh ◽

Y. Sato ◽

M. Takemoto ◽

D. Uchida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Open Label ◽

Dipeptidyl Peptidase 4 ◽

Glucosidase Inhibitor ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor sitagliptin compared with alpha‐glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin‐1): A multicenter, randomized, open‐label, non‐inferiority trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12282 ◽

2014 ◽

Vol 6 (2) ◽

pp. 182-191 ◽

Cited By ~ 12

Author(s):

Hidetaka Yokoh ◽

Kazuki Kobayashi ◽

Yasunori Sato ◽

Minoru Takemoto ◽

Daigaku Uchida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Dipeptidyl Peptidase 4 ◽

Glucosidase Inhibitor ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Alpha Glucosidase ◽

Control Diabetes

Download Full-text

Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24‐week, open‐label, controlled trial ( STOP‐OB )

Diabetes Obesity and Metabolism ◽

10.1111/dom.14059 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1659-1663 ◽

Cited By ~ 1

Author(s):

Toru Kitazawa ◽

Hiroaki Seino ◽

Hiroshi Ohashi ◽

Takeshi Inazawa ◽

Masahiro Inoue ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Dipeptidyl Peptidase ◽

Oral Agent ◽

Open Label ◽

Dipeptidyl Peptidase 4 ◽

The Third ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)

Diabetology International ◽

10.1007/s13340-020-00426-w ◽

2020 ◽

Vol 11 (3) ◽

pp. 274-282

Author(s):

Yuichi Terawaki ◽

◽

Chikayo Iwaya ◽

Takashi Nomiyama ◽

Dai Shimono ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Insulin Secretagogue ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2008.01016.x ◽

2009 ◽

Vol 11 (2) ◽

pp. 167-176 ◽

Cited By ~ 114

Author(s):

R. E. Pratley ◽

M. S. Kipnes ◽

P. R. Fleck ◽

C. Wilson ◽

Q. Mekki ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2016.03.011 ◽

2016 ◽

Vol 116 ◽

pp. 86-95 ◽

Cited By ~ 16

Author(s):

Yeong Gi Kim ◽

Se Hee Min ◽

Seokyung Hahn ◽

Tae Jung Oh ◽

Kyong Soo Park ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes

Diabetic Medicine ◽

10.1111/j.1464-5491.2010.03181.x ◽

2011 ◽

Vol 28 (4) ◽

pp. 464-469 ◽

Cited By ~ 7

Author(s):

J. Rosenstock ◽

A. J. Lewin ◽

P. Norwood ◽

V. Somayaji ◽

T. T. Nguyen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2017.10.018 ◽

2018 ◽

Vol 138 ◽

pp. 253-261 ◽

Cited By ~ 8

Author(s):

Philip Home ◽

R. Ravi Shankar ◽

Ira Gantz ◽

Carol Iredale ◽

Edward A. O'Neill ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dipeptidyl Peptidase ◽

Double Blind Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Dipeptidyl Peptidase 4 ◽

Blind Trial ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Comparative Efficiency of Sulfonylurea and/or Dipeptidyl Peptidase-4 inhibitor in Basal-Supported Oral Therapy in Japanese Patients with Type 2 Diabetes (JDDM39)

Journal of Diabetes and Obesity ◽

10.15436/2376-0949.15.030 ◽

2015 ◽

Vol 2 (3) ◽

pp. 1-6

Author(s):

Keiko Arai ◽

Keyword(s):

Type 2 Diabetes ◽

Oral Therapy ◽

Japanese Patients ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Comparative Efficiency ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Basal Supported Oral Therapy

Download Full-text

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00744.x ◽

2007 ◽

Vol 9 (5) ◽

pp. 733-745 ◽

Cited By ~ 360

Author(s):

K. Hermansen ◽

M. Kipnes ◽

E. Luo ◽

D. Fanurik ◽

H. Khatami ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1335637 ◽

2017 ◽

Vol 33 (10) ◽

pp. 1853-1860 ◽

Cited By ~ 7

Author(s):

R. Ravi Shankar ◽

Silvio E. Inzucchi ◽

Victoria Scarabello ◽

Ira Gantz ◽

Keith D. Kaufman ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Dipeptidyl Peptidase ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Metformin Monotherapy ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text